Utah Medical Products UTMD

NASDAQ UTMD
$74.82 -0.25 (-0.33%)
As of: Oct 21, 2026 · 10:38 AM EDT

Utah Medical Products (UTMD) stock price is $74.82, down 0.33% on the day, as of Oct 21, 2026. It has a market cap of $238.24Mn and a P/E ratio of 22.72, and is classified in the Medical Devices industry (Healthcare sector).

Key Stats
Market Cap238.24 Mn
P/E22.72
P/S6.60
Div. Yield0.00
Total Debt (Qtr)195,000.00
Revenue Growth (1y) (Qtr)-14.31
Add ratio to table…

About

Utah Medical Products, Inc. designs manufactures and markets high quality cost effective medical devices that are distinguished by safety and improved patient outcomes. The company was formed as a Utah corporation in 1978 and completed its initial public offering in 1982. Over the decades it has built a broad product portfolio that serves labor and delivery neonatal intensive care and women's health markets. Utah Medical Products also supports outpatient clinics and…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue is generated from the design, manufacture, and sale of medical devices such as fetal monitoring accessories, intrauterine pressure catheters, and neonatal respiratory hoods sold to hospitals and clinics. A secondary sector of Industrials is justified because the company maintains a distinct business line providing contract manufacturing (OEM) services for both medical and non-medical device firms. Industries: Medical Devices Medical Devices Primary The company designs and manufactures therapeutic and surgical medical devices, specifically fetal monitoring accessories, intrauterine pressure catheters, and vacuum assisted delivery systems. These products are sold directly to hospitals, labor and delivery suites, and neonatal intensive care units. Contract Manufacturing Contract Manufacturing Secondary The company earns income by manufacturing components and finished devices on a subcontract basis for other medical device and non-medical device firms, including OEM customers like PendoTECH. Classified using BQ-MICS CIK: 0000706698

Geographical Breakdown of Revenue (2025)

History

Statement Geographical Breakdown of Revenue (2025)

History
Peer percentiles

How Utah Medical Products ranks

Ranked against the 248 companies in Medical Devices and Diagnostics58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 22.7xMedian 28.9x 89th
  • P/FCF 20.8xMedian 26.0x 84th
  • P/Operating cash flow 20.1xMedian 20.1x 78th
  • P/S 6.60xMedian 3.07x 27th
  • P/B 1.95xMedian 2.40x 56th
  • P/Tangible book 1.96xMedian 3.05x 62nd
  • EV/EBITDA 11.9xMedian 18.0x 90th
  • EV/EBIT 14.7xMedian 27.8x 96th
  • EV/Revenue 4.19xMedian 3.25x 39th
  • EV/FCF 13.2xMedian 26.6x 94th
  • EV/Operating cash flow 12.8xMedian 21.9x 91st
  • PEG (3Y EPS CAGR)EPS is not growing −1.99Median 0.86 Not meaningful —
Peer group

Peer Comparison

Companies in the Medical Devices
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 260.30 Bn37.365.6242.55 Bn
2 ABT Abbott Laboratories 170.90 Bn31.503.6732.61 Bn
3 DHR Danaher Corp /De/ 164.81 Bn41.166.5626.56 Bn
4 ISRG Intuitive Surgical Inc 152.46 Bn48.5713.82-
5 MDT Medtronic plc 119.28 Bn22.803.1828.15 Bn
6 SYK Stryker Corp 112.91 Bn30.284.3714.94 Bn
7 BSX Boston Scientific Corp 64.87 Bn17.653.0912.62 Bn
8 UTMD Utah Medical Products Inc 0.24 Bn22.726.600.00 Bn